Stocks and Investing Stocks and Investing
Tue, April 18, 2023
[ 12:00 AM ] - WOPRAI
Jeremy Tonet Maintained (WMB) at Buy with Decreased Target to $35 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Tobey Sommer Initiated (WM) at Strong Buy and Held Target at $190 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Meyer Shields Maintained (WRB) at Buy with Decreased Target to $53 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Amit Dayal Reiterated (VTNR) at Strong Buy and Held Target at $15 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Noah Kaye Reiterated (VTNR) at Buy and Held Target at $14 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Roger Read Downgraded (VLO) to Hold and Held Target at $135 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Michael Ward Maintained (WTW) at Hold with Increased Target to $256 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Meyer Shields Maintained (WTW) at Buy with Decreased Target to $289 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Stephen Tusa Maintained (WSO) at Hold with Increased Target to $288 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Scott Buck Reiterated (XWEL) at Strong Buy and Held Target at $20 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Paul Chung Maintained (YOU) at Hold with Decreased Target to $30 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Marc Solecitto Maintained (WES) at Buy with Decreased Target to $32 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Tobey Sommer Initiated (WCN) at Strong Buy and Held Target at $160 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Ari Wald Maintained (WCN) at Buy with Increased Target to $152 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Brian Dobson Maintained (WBX) at Strong Buy and Held Target at $12 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Mike Genovese Maintained (VIAV) at Strong Buy with Decreased Target to $13 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Connor Lynagh Maintained (VIAV) at Hold with Decreased Target to $11 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Mehdi Hosseini Maintained (VIAV) at Buy with Decreased Target to $14 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Dave Kang Maintained (VIAV) at Hold with Decreased Target to $11 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Timothy Thein Maintained (URI) at Strong Buy with Decreased Target to $450 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Matthew Carletti Initiated (AMSF) at Buy and Held Target at $65 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Simon Flannery Maintained (AMT) at Hold with Decreased Target to $215 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Michael Ward Maintained (AON) at Hold with Increased Target to $344 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Matthew Barcus Reiterated (ANIX) at Strong Buy and Held Target at $9 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Yi Chen Reiterated (ANIX) at Strong Buy and Held Target at $12 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Mark Schappel Maintained (ANSS) at Hold with Increased Target to $315 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Roger Read Maintained (APA) at Buy with Decreased Target to $50 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Michael Ward Upgraded (CB) to Strong Buy and Held Target at $229 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Matthew Carletti Reiterated (CB) at Buy and Held Target at $250 on, Apr 18th, 2023
[ 12:00 AM ] - WOPRAI
Joseph Stringer Reiterated (CARA) at Buy and Held Target at $22 on, Apr 18th, 2023

Joseph Stringer Reiterated (CARA) at Buy and Held Target at $22 on, Apr 18th, 2023


Published on 2024-10-28 02:50:31 - WOPRAI, Joseph Stringer
  Print publication without navigation


Joseph Stringer of Needham, Reiterated "Cara Therapeutics, Inc." (CARA) at Buy and Held Target at $22 on, Apr 18th, 2023.

Joseph has made no other calls on CARA in the last 4 months.



There are 5 other peers that have a rating on CARA. Out of the 5 peers that are also analyzing CARA, 0 agree with Joseph's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Joseph

  • Jason Gerberry of "B of A Securities" Downgraded from Hold to Sell and Decreased Target to $6 on, Wednesday, March 8th, 2023
  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $20 on, Tuesday, March 7th, 2023
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $25 on, Tuesday, March 7th, 2023
  • Daniel Wolle of "JP Morgan" Maintained at Buy with Decreased Target to $16 on, Tuesday, March 7th, 2023
  • David Amsellem of "Piper Sandler" Maintained at Buy with Decreased Target to $13 on, Tuesday, March 7th, 2023
Contributing Sources